NEWPORT — SaVida Health, an outpatient medication-assisted treatment for opioid and alcohol addiction, is opening a new treatment center in Newport.
The center is scheduled to open September 12, and is located in the Hood Building at 79 Coventry Street, Suite 4C.
SaVida Health Newport will be the company’s third location in Vermont, with other practices in Bennington and Springfield.
The center will be administering medications like Suboxone, Sublocade, and Vivitrol, and clinical professionals will also deliver treatment that includes medical care, counseling, case management, and long-term support through either weekly, biweekly or monthly visits.
In particular, SaVida focuses on addressing the social determinants of health to support its patients who might be experiencing circumstances like food insecurity, homelessness, or unemployment.
This comprehensive and integrated approach to recovery is widely accepted as the most effective form of outpatient treatment for opioid and alcohol addiction today.
“While methadone is an option for patients requiring a highly structured daily program, there are far more benefits to the buprenorphine-based medicines we prescribe,” said Dr. Sue Cary, medical director at SaVida Health.
Unlike methadone, there is no euphoric high or cognitive impairment with buprenorphine. Because there is a ceiling effect, dose levels can be decreased over time. With methadone, patients build up a tolerance which requires an increase in dosage over time. Also, it is easier for most people to reclaim their lives with scheduled, weekly or monthly appointments” said Dr. Sue Cary, medical director at SaVida Health.
SaVida Health Newport is currently accepting patients for the week of September 12.
Once open SaVida says they can see most patients either the same day or the next business day.
